MHRA to link with overseas regulators post-Brexit
The UK is to join two initiatives which bring together medicines regulators and allow pharmaceutical companies to submit medicines to be reviewed by several countries at the same time, pooling resources and allowing patients to benefit from earlier access.
The two schemes are:
- Project Orbis - a programme coordinated by the US Food and Drug Administration (FDA) involving Canada, Australia, Switzerland, Singapore and Brazil to review and approve promising cancer treatments.
- The Access consortium, involving Australia, Canada, Switzerland and Singapore to help secure improved patient access to medicines. The consortium has previously approved nine prescription medicines, including five new cancer treatments.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA), which currently operates under the umbrella of the European Medicines Agency, will participate as an observer of both groups before the end of 2020 and will be a full participant from 1 January 2021 after the EU transition period.
Pharmaceutical companies that submit applications to some or all of the five Access countries will benefit from having their products evaluated for marketing in those countries simultaneously with reduced evaluation times.
MHRA will still have the authority to make the final decision to authorise medicines onto the UK market and will have complete autonomy to streamline the approval processes even further if needed outside of both schemes.
Upgrade your contraceptive consultations by exploring the interactive pack to learn about a daily oral contraceptive pill
Common feeding feeding issues, including coloc, reflux and regurgitation, and some of the ways they can be managed
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
Feel the power with Covonia's new pharmacy only sore throat range
NEW Covonia Medicated Sore Throat 5mg/1mg Lozenges have a dual action formula that numbs pain and fights infection. A Pharmacy Magazine and Thornton & Ross promotion
6 Min Article
GPs disregard pharmacist recommendations in new study
GPs trialling a new model of care were often reluctant to follow pharmacist recommendations, say researchers.
4 Min Article
Benefits of steroids in inhalers outweighs risk say researchers
The advantages of using inhalers and nebulisers containing steroids outweigh the risks, claim researchers.Â
2 Min Article
Government makes it easier to recruit overseas pharmacists
The Government has made it easier for overseas pharmacists to come to the UK by adding the profession to the Shortage Occupation List.
2 Min Article